AI Article Synopsis
- - This study investigates liver cancer medical costs in urban China from 2002 to 2011, revealing a significant rise in average treatment expenses from ¥21,950 to ¥40,386 over the decade.
- - An analysis of 12,342 patients shows that pharmaceutical expenses constitute the largest portion of costs, rising from 48.01% to 52.96%, while nursing fees remain minimal at about 1%.
- - The findings indicate that liver cancer imposes a heavy economic burden on families, with early diagnosis and treatment potentially reducing costs; expenditures are notably higher in the eastern region compared to the west and central areas.
Article Abstract
Objective: This study aims to understand the medical expenditure for liver cancer during 2002-2011 in urban areas of China.
Materials And Methods: This is a retrospective study. Based on a stratified cluster sampling method, a medical expenditure survey collected basic personal information from related medical records. Two-tailed independent sample t-test, variance analysis, and Student-Newman-Keuls Tests were used in cost analysis for the corresponding data types.
Results: A total of 12,342 liver cancer patients were included in the analysis. Overall average medical expenditure per case for liver cancer diagnosis and treatment in China has increased from ¥21, 950 to ¥40, 386 over the study period. For each liver cancer patient diagnosed between 2009 and 2011, the average expenditures were 29,332 CNY for stage I, 35,754 CNY for stage II, 34,288 CNY for stage III, and 30,275 CNY for stage IV diseases (P < 0.001). Pharmaceuticals accounted for the biggest part of the medical expenditure and it rose from 48.01% to 52.96% during these ten years, and the share of nursing fee expenses was the lowest (around 1%). Over the entire 10-year data period, the per capita expenditure of the east region (32,983 CNY) was higher than that of the west region (26,219 CNY) and slightly higher than the central region (31,018 CNY, P < 0.001).
Discussion: As a major cancer in China, liver cancer accounts for a large portion of health economic burden and its medical expenditure is heavy for families. Early diagnosis and treatment for liver cancer will save medical expenditure.
Conclusion: The economic burden of liver cancer is high in China and related medical expenditure has increased.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4103/jcrt.JCRT_709_16 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!